Roohi Mariam Peter, Author at Labiotech.eu

About

Having completed a master’s programme in International Journalism from Cardiff University in 2022, I have written about various subjects including culture, politics, social justice, mental health, LGBTQ+ issues and gender. My undergraduate degree in life sciences has equipped me to explore my passion for reporting on health, science and the environment. When I’m not transcribing interviews and fretting about deadlines, I like to spend my time reading, watching movies, and making lousy mixtapes for a potential side career in rap music.

Articles by Roohi Mariam Peter

In Depth 16 Nov 2023

uniQure: is the gene therapy pioneer en route to becoming a biotech rebuff?

Once thought to be a frontrunner in gene therapy, uniQure’s fame may no longer be coveted, as the biotech looks to reorganize by slashing its workforce, in an attempt to stay afloat. But how did things go awry for the company that was once in its prime in the DNA game? The Danish company, which […]

November 16, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 9 Nov 2023

Blood tests for Alzheimer’s: a hit or a miss?

Doctor’s typically diagnose Alzheimer’s with the help of brain imaging and cognitive tests, along with taking a patient’s medical history into account. But lately, blood tests are gaining recognition for its ability to rule out other potential causes of memory loss, and to diagnose Alzheimer’s more quickly. With American healthcare company Labcorp launching its trio […]

November 9, 2023 - 10 minutesmins - By Roohi Mariam Peter

Best in Biotech 7 Nov 2023

Eight biotech companies tackling infectious diseases head-on

Infectious diseases are diseases that are caused by pathogens that enter the body, hijack the body’s immune system and multiply, causing an infection. Five of the deadliest infectious diseases are measles, tuberculosis, malaria, diarrhoeal disease and influenza, according to the World Economic Forum. While Our World in Data statistics suggest that there has been almost […]

November 7, 2023 - 11 minutesmins - By Roohi Mariam Peter

Best in Biotech 31 Oct 2023

Six biotech companies in Melbourne that have been making the news

Located on the southeastern coast of Australia, Melbourne is one of the leading life science hubs in the Asia Pacific region, according to a CBRE report published in 2021. With more and more investors taking an interest in the Melbourne region, this contributes to the country’s market value of $170 billion in the sector, with […]

October 31, 2023 - 9 minutesmins - By Roohi Mariam Peter

In Depth 27 Oct 2023

Big pharma monopolies: major antitrust cases over the past decade

Antitrust laws are put in place to prevent unlawful activities like price fixing, as well as monopolies from forming, typically tied to big pharma. If these powerful companies were to swallow smaller biotechs in an attempt to fix prices, it would stifle competition, result in limited options for consumers, thereby leading to a rise in […]

October 27, 2023 - 11 minutesmins - By Roohi Mariam Peter

In Depth 16 Oct 2023

Blockchain-based biotech: is this a viable financing method?

At a time when biotechs are scrambling to raise funds, a new way for startups to secure investments is emerging: leveraging cryptocurrency. The motive behind decentralized financing seems pretty ambitious – to democratize funding in healthcare. But does it live up to the hype? With VitaDAO – a decentralized collective that funds early-stage startups looking […]

October 16, 2023 - 10 minutesmins - By Roohi Mariam Peter

In Depth 12 Oct 2023

Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?

The immune system protects our bodies from foreign invaders, but sometimes, when it malfunctions, it can result in life-threatening autoimmune disorders. But what if the immune system could be regulated to counter these diseases? Immunometabolism, an emerging field in therapeutics, aims to rein in autoimmunity altogether. According to Neil Weir, chief executive officer (CEO) of […]

October 12, 2023 - 9 minutesmins - By Roohi Mariam Peter

Best in Biotech 10 Oct 2023

Bridging Science and Art: Five bioartists you should know about

Bioartists bridge art, born out of creativity and abstract thoughts, and science, which is rooted in facts, laws and logic, as a means of self-expression. The term bioart was coined by Brazilian-American artist Eduardo Kac, who implanted a microchip in his ankle on live television, and registered himself in a pet database, as both the […]

October 10, 2023 - 10 minutesmins - By Roohi Mariam Peter

In Depth 6 Oct 2023

Will the U.S. Cancer Moonshot program land its target to halve cancer death rates?

It was predicted that more than 600,000 people would die from cancer last year in the U.S., according to the American Cancer Society. But what if those figures could be halved over the next couple of decades? Although no small feat, that’s precisely what the Cancer Moonshot program aims to do. The White House initiative, […]

October 6, 2023 - 10 minutesmins - By Roohi Mariam Peter

In Depth 4 Oct 2023

CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?

Riding on the success of CAR-T cell therapy, a breakthrough in the treatment of blood cancers, CAR-NK therapies are an emerging field in therapeutic research that aim to boost an even stronger immune response against cancer. What is CAR-NK cell therapy? Natural killer (NK) cells, like T cells, are white blood cells that are a […]

October 4, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 2 Oct 2023

PIPEs in biotech fundraising: is this growing trend fueled by economic uncertainty here to stay?

This past year has not been very sympathetic to fundraisers in the biotech industry. As the economic downturn grinds on, many companies are in need of funds to stay afloat. A recent trend in the way biotechs have secured funding, might be telling of how these companies are determined to pull through. A private investment […]

October 2, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 29 Sep 2023

Illumina: DNA giant in troubled waters

A botched acquisition deal and unrest among company investors amid plummeting stocks have plagued Illumina, which was once part of the biotech big leagues that dominated the field of gene sequencing. Now, in fear of losing its ground to other players in the space, it has received a European Commission order to divest Grail, and […]

September 29, 2023 - 8 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Roohi Mariam Peter

About

Articles by Roohi Mariam Peter

uniQure: is the gene therapy pioneer en route to becoming a biotech rebuff?

Blood tests for Alzheimer’s: a hit or a miss?

Eight biotech companies tackling infectious diseases head-on

Six biotech companies in Melbourne that have been making the news

Big pharma monopolies: major antitrust cases over the past decade

Blockchain-based biotech: is this a viable financing method?

Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?

Bridging Science and Art: Five bioartists you should know about

Will the U.S. Cancer Moonshot program land its target to halve cancer death rates?

CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?

PIPEs in biotech fundraising: is this growing trend fueled by economic uncertainty here to stay?

Illumina: DNA giant in troubled waters

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Roohi Mariam Peter

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!